Sleep disorders are conditions that disrupt how easily a person falls asleep, how long they stay asleep, or how rested they feel on waking, and they range from common complaints such as insomnia to rare syndromes. Red light therapy (RLT) uses red and near-infrared light to influence the body at a cellular level, and a growing body of research asks whether it can ease these disorders and improve sleep.
This guide weighs what human studies of red light therapy show across five areas of sleep: sleep apnea, insomnia, sleep quality, circadian rhythm disorders, and Kleine-Levin syndrome, and what they do not, down to the wavelengths, doses, and side effects some trials recorded.
The evidence divides sharply across those five conditions. Sleep quality carries the strongest case, insomnia a mixed one, and sleep apnea none at all. Where three or more human studies exist, a condition carries a CURE Index, which includes a score from 0 to 100 and a plain verdict (Effective, Mixed Evidence, or Not Effective). Across all five, the studies used red and near-infrared light at wavelengths between 633 and 870 nanometers (nm), among which 660 nm and 850 nm appeared most often.
Sleep Apnea
Sleep apnea is a breathing disorder that repeatedly stops airflow during sleep. The soft tissues at the back of the throat relax and block the airway. Breathing pauses, oxygen dips, and sleep fragments without the sleeper noticing, leaving daytime tiredness and added strain on the heart. Continuous positive airway pressure (CPAP) remains the gold standard treatment, though the equipment costs a great deal and many patients never adapt to it.
That adaptation gap is what turned researchers toward light. Low-level laser therapy (LLLT), a form of photobiomodulation, targets the collapsing tissue directly instead of holding the airway open with pressurized air the way CPAP does. Researchers target the oral cavity because it carries a dense blood supply, and they expect light delivered there to improve vascular function alongside autonomic and hemodynamic control. They designed one trial to test that expectation, but so far, it has produced no results.
That trial came from Camargo and colleagues at Nove de Julho University in São Paulo, Brazil, who published the design in Medicine in 2020. It calls for 36 sedentary adults aged 30 to 60 who screen high-risk on the Berlin questionnaire and confirm moderate to severe apnea on a sleep study. Half receive 808 nm laser light at 8 points across the soft palate and tongue base, 8 seconds per point at 250 milliwatts, delivering 2 joules per point and 16 joules per session. Half receive the same routine from a device switched off. Sessions run twice a week for 2 months, 16 in total. The design expects fewer breathing interruptions per hour, measured as the apnea-hypopnea index (AHI). That expectation remains untested.
Insomnia
Insomnia is a sleep-wake disorder defined by persistent difficulty initiating sleep, maintaining sleep, or returning to sleep after early awakening, despite adequate opportunity to sleep. The International Classification of Sleep Disorders, Third Edition (ICSD-3) sets the chronic threshold at 3 nights per week for 3 months. Insomnia develops from shifted body clocks, evening light, and ongoing stress, and produces daytime fatigue, poor concentration, and low mood. Hyperarousal drives that cycle, so the brain stays alert at bedtime instead of settling.
Red light therapy (RLT), or photobiomodulation (PBM), targets that alert brain with red and near-infrared light between 660 and 870 nanometers (nm). Two placebo-controlled trials outside the Sleep Quality score have tested it on insomnia and related sleep complaints, and both improved how people rated their own sleep. However, neither improved sleep as an instrument measured it. Both trials delivered 810 nm through two different routes: transcranial photobiomodulation (tPBM) through the forehead, and an emitter collar around the neck. The front of the brain fires excess slow-wave delta activity during waking hours in people with insomnia, and tPBM acts on the excess. Researchers classify the effect as neuromodulation: the light retunes electrical firing rather than releasing a chemical.
In 2025, Mehdizadeh and colleagues at Tabriz University tested the forehead route in a randomized controlled trial on 30 adults with chronic insomnia. Half received 810 nm light at 60 J/cm², 10 minutes per session across 3 days, and half received a fake device. The light group's sleep quality improved by 4.6 points compared with the fake group on the Pittsburgh Sleep Quality Index (PSQI). Daytime sleepiness fell by 4.1 points on the Epworth Sleepiness Scale (ESS). The excess delta activity at the front of the brain dropped. No serious side effects appeared. The authors called the method a promising and safe way to retune the faulty brain timing behind chronic insomnia.
In 2023, Kennedy and colleagues at the University of Arizona tested the collar route in a 5-week trial published in the Journal of Clinical Sleep Medicine, with 30 adults aged 30 to 60 who reported poor sleep without a diagnosed sleep disorder. Participants completed a 2-week baseline, then wore either an active collar emitting 660, 740, 810, and 870 nm together or a fake one, every other night before bed for 3 weeks. Active users reported better sleep, relaxation, and mood. However, their wrist trackers recorded no change in measured sleep, and insomnia severity scores improved in the fake group too. The authors asked for more work on the right dose, wavelength, and power level.
Sleep Quality
Sleep quality is how well a person sleeps, including how easily they fall asleep, how rarely they wake in the night, and how rested they feel on waking. Sleep quality declines with shift work, irregular schedules, aging, and evening screen light, and that decline drains next-day energy, mood, and focus.
For sleep quality, the CURE Index returns a verdict of Effective with a score of 95 out of 100, inside the Strong Confidence band. 4 human studies covering 300 participants produced that score, and the scientific evidence on sleep quality records improvement in each one. The most cited wavelength across studies is 850 nm.
Circadian Rhythm Disorders
Circadian rhythm disorders occur when the body's internal clock drifts away from the day-night cycle, making it hard to fall asleep and wake at ordinary times. They arise from night-shift work, frequent flying, and late-night light exposure, and lead to disturbed alertness, mood, and appetite.
Red light therapy acts on the nervous system behind those disturbances rather than on the clock itself. Night-shift work tips the autonomic nervous system toward stress and away from its rest-and-recover side. Researchers tested whether light moves it back. They chose laser acupuncture, which delivers a low-power beam to a single point on the body instead of spreading light across a wide area, and they tracked the result through heart rate variability, the small beat-to-beat changes in heart rhythm that show which way the balance has moved. One trial has applied it to shift workers.
In 2009, Wu and colleagues at Ming Chuan University in Taiwan ran a randomized controlled trial on 30 healthy men working night shifts. 15 received 830 nm laser light at the Neiguan point (PC6) on the inner wrist, 9.7 joules per square centimeter across 10 minutes, against 15 on a sham beam. The team took heart rate variability readings before, after, and 30 minutes later, and the laser group shifted toward the rest-and-recover side on all three. The authors concluded that the treatment "increased vagal activity and suppression of cardiac sympathetic nerves" and "suggested it for patients who have circadian rhythm disorders." However, both groups changed significantly on those same readings, the trial ran a single session with no follow-up, and none of the men had a diagnosed circadian disorder. The study measured no circadian outcome, so that second claim is a suggestion rather than a finding.
Kleine-Levin Syndrome
Kleine-Levin syndrome (KLS), or Sleeping Beauty syndrome, is a rare neuropsychiatric disorder that returns in episodes of two to three weeks, each bringing near-constant sleep, confusion, memory trouble, and shifts in appetite and mood, with full recovery in between. No cure exists, so clinicians work through drugs by trial and error. The cause also remains unconfirmed, but researchers point to genetics, autoimmune activity, or faulty signaling in the thalamus and hypothalamus (the deep brain structures that govern sleep and appetite).
Red light therapy has entered KLS research as an experimental option. Many patients with KLS have poor blood flow and low energy output in the thalamus and hypothalamus. Red light lands on the mitochondria inside cells, the parts that make energy, and pushes them to produce more. Intranasal photobiomodulation (i-PBM) sends that light through the nostril, into dense blood vessels and smell-nerve endings that sit just below the frontal lobe. The light goes no deeper, so any effect further into the brain travels by blood. One published case has tried it, on an 18-year-old man with KLS.
In 2021, Hamper and colleagues at Florida Atlantic University reported an 18-year-old man who was three years into KLS. Lithium had cut his episodes from monthly to twice a year, and four other drugs did nothing. A flu-like illness then triggered an episode lasting nearly 6 months. His family agreed to intranasal red light at 633 nm, 25 minutes a night in one nostril, 12 joules per session, with 10 milligrams of methylene blue by mouth an hour before. Symptoms lifted within a week, and two years on, he had no relapse, no reported side effects, and no other medication. However, the authors name three limits. The light never traveled alone, and methylene blue acts on the same mitochondrial pathway. One patient is not a trial. KLS fades on its own, so natural remission stays in play.
Does Red Light Therapy Really Help with Sleep?
Yes. In most trials on this page, people reported better sleep after red light therapy, with the best evidence in general sleep quality and the least for sleep apnea. Four separate effects drive the result, running from the energy inside cells to the hormone that makes you sleepy called melatonin. Dose and timing shape the outcome. The trials that reported better sleep ran sessions of 10 to 180 minutes, some taken before bed, and most repeated over several weeks. The studies on this page reported no serious side effects.
How Red Light Exposure can Improve Your Sleep?
Red light therapy acts on sleep by lifting energy production in the mitochondria, calming overactive delta waves during waking hours, shifting the nervous system to its parasympathetic rest state, and leaving melatonin intact where blue light suppresses it.
How to Use Red Light Therapy for Better Sleep?
To use red light therapy as the sleep trials did, expose your head, face or neck to 633 to 870 nm red and near-infrared light for 10 to 30 minutes before bed, and repeat 3 to 5 times a week for 3 to 6 weeks while keeping the room dark and screens off. However, according to a 2011 review by Huang and colleagues in Dose-Response, more light is not better. Past a certain dose, the effect levels off and then reverses, so longer sessions and higher settings work against the result.
How Long before Bed should I use Red Light Therapy?
Use red light therapy 30 to 60 minutes before bed. According to a study by Figueiro and colleagues at the Lighting Research Center, red light raised alertness at night in shift workers without suppressing melatonin, and 30 to 60 minutes lets that alerting effect fade before lights-out. While this is the standard measure, it is always advised to follow the instructions that come with the device to avoid any side effects.
Are there any Side Effects of Using Red Light for Sleep?
Red light therapy is generally safe and well tolerated. It contains no UV radiation and is non-invasive, and studies report no serious side effects. A small number of people notice mild, temporary effects such as eye strain, dizziness, or headache, usually from inadequate eye protection or increased blood circulation. Anyone taking medication that raises light sensitivity must consult with a clinician before starting.
Do Helio Cure Panels Use the Wavelengths Studied for Sleep Disorders?
Yes. Helio Cure panels run 630, 660, 810, 830, 850, and 1064 nm. Four of them, 660, 810, 830, and 850 nm, were used in the sleep trials on this page. The sleep quality studies cite 850 nm most often, and both insomnia trials on this page used 810 nm.
References
- https://journals.sagepub.com/doi/10.1089/pho.2007.2235
- https://pmc.ncbi.nlm.nih.gov/articles/pmid/37141002/
- https://dx.doi.org/10.1007/s10103-025-04699-y
- https://pmc.ncbi.nlm.nih.gov/articles/pmid/34659921/
- https://pmc.ncbi.nlm.nih.gov/articles/pmid/32195961/
- https://journals.sagepub.com/doi/abs/10.1177/1099800415572873
- https://www.ncbi.nlm.nih.gov/books/NBK526136/
- https://pmc.ncbi.nlm.nih.gov/articles/PMC3315174/
- https://pmc.ncbi.nlm.nih.gov/articles/PMC6041198/